GCG and short bowel syndrome: GLP-2 is a specific growth factor with intestinal protective effect, which can enhance the transport of glucose and lipid in intestinal cells, enhance nutrient absorption and promote intestinal adaptation.536 Teduglutide is a GLP-2 analogue that was previously approved by EMV in 2012 for the treatment of short bowel syndrome and malabsorption.